Diagnostic Biomarker Market - Global Industry Analysis and Forecast 2017 - 2025


Persistence Market Research

$ 4900

The demand within the global diagnostic biomarker market has been rising on account of advancements in the field of medical testing. Several types of diseases can be diagnosed with the help of biomarkers, and this is a key consideration from the perspective of market growth. The introduction of biomarkers was followed by a series of changes in medical diagnostic field. Hence, the relevance of diagnostic biomarkers cannot be undermined within the medical fraternity. Surrogate is a type of biomarker that is commonly used for the diagnosis of a number of diseases. Furthermore, the presence of diagnostic biomarkers can help in early detection or diagnosis of a particular disease. The results from diagnostic biomarkers can be combined with the insights gains during physical examination. This helps in developing a sound line of treatment with respect to the patient’s medical condition. Hence, the global diagnostic biomarker market is expected to accumulate huge-scale revenues in the years to follow. 

  • Apart from helping in diagnosis of diseases, biomarkers can also provide information about a particular disease state. 
  • Hence, the global diagnostic biomarker market is projected to expand at a boisterous pace in the years to come by. 
  • The presence of antibodies is an indication of possible infections in the body, and the presence of antibodies can also be detected with biomarkers. 

On the basis of geography, the global diagnostic biomarker market can be segmented into Latin America, Europe, Asia Pacific, the Middle East and Africa, North America, and Asia Pacific. The diagnostic biomarker market in North America is expected to outgrow all other regional markets.

Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.

Biomarkers provides an approach in understanding the dynamics of neurological disease with contribution in applications of analytical epidemiology and clinical trials. Diagnostic biomarkers can extend the base of information of the underlying pathology of a disease along with providing means for homogeneous classification of a disease possible factors that are risk for the body. Biomarkers are vital agents that can provide the information about the disease starting with the initiation of the disease till its terminal stage. The requirement for the perfect diagnosis is the careful assessment of the validity of biomarkers with respect to the stage of any disease. Furthermore, causes varies from individual to laboratory.

Revenue growth in the diagnostic biomarker is expected to gain traction in the near future as they are dependent on the prevalence of diseases such as cancer and other cardiac problems. Significant growth the sector of molecular biology and advancements in various laboratory techniques is expected to support the diagnostic biomarker market over the forecast period. The advancement in the technology and rise in adoption rate of the biomarkers in diagnosis has expanded the feasibility of the use of biomarkers in diagnosis of various disorders such as genetic, cardiac, cancer and other immunological diseases. Also, for clinical investigators the biomarkers can be a dynamic and powerful tool to analyze the spectrum of neurological disease.

Global diagnostic biomarker market is segmented on the basis of product type, application and end-user

  • Segmentation by product type
    • S100
    • MART-1
    • gp100
    • HMB45
    • AFP
    • BCR-ABL
    • Others
  • Segmentation by application
    • Risk assessment
    • Molecular diagnostics
    • Drug discovery & development
    • Forensic applications 
  • Segmentation by end-user
    • Hospitals
    • Cancer research institutes
    • Diagnostic Labs

Diagnostic biomarkers can be effective for veterinary purpose in canine pyometra and sepsis where the cytokines are used as diagnostic biomarkers. In both human and animals the incidence, severity and mortality rates under sepsis is significantly on the rise. Various experiments have been conducted to extract the best use of the biomarkers in diagnosis. Current experimental models of sepsis provide promising results although they are not able to reflect actual scenario in terms of clinical outcomes of sepsis syndrome. However, the study supports the use of diagnostic biomarkers but the main problem in sepsis is the weakness of the clinical diagnostic criteria. Numerous biological molecules are being tested for the ability to know the onset of sepsis and distinguish between sterile and infection-caused inflammation However, none of the evaluated biomarkers can be applied for routine clinical use in diagnosis of sepsis. The above fact is expected to somehow impede the growth for diagnostic biomarker market in the near future.

However, there are some more factors that impede the market such as the availability of the resources and limited studies related to the diagnostic biomarkers. Factors such as specificity of the disease, complications during the assessment of the technique is expected to resist the growth for diagnostic biomarker market.

By region, diagnostic biomarker market is segmented into five regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America dominates the global diagnostic biomarker market due to extensive use of the technology in research and development process followed by Western Europe and Japan in Asia Pacific region. However, growth in other Asian regions is projected to grow with an increase in demand for research process due to the more prevalence of cardiac disorders and cancer.

Some of the player in the near infrared spectroscopy devices market are Biocrates Life Sciences AG, Augurex Life Sciences Corp., Biomedical Corp., Target Discovery, Banyan Biomarkers, Inc., Astute Medical, Inc., Axela Inc.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

  • Tailwinds and headwinds molding the market’s trajectory
  • Market segments based on products, technology, and applications
  • Prospects of each segment
  • Overall current and possible future size of the market
  • Growth pace of the market
  • Competitive landscape and key players’ strategies

The main aim of the report is to:

  • Enable key stakeholder’s in the market bet right on it
  • Understand the opportunities and pitfalls awaiting them
  • Assess the overall growth scope in the near term
  • Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.